Finnish study maps the Real-World journey of advanced prostate cancer

NCT ID NCT05701007

Summary

This study looked back at the medical records of over 1,000 men in Finland with advanced prostate cancer that had spread. Its goal was to understand who gets this disease, what treatments they receive, and how well those treatments work in everyday practice. By analyzing this real-world data, researchers aim to improve future care and understand the full impact of the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Pfizer

    Helsinki, Finland

Conditions

Explore the condition pages connected to this study.